Compile Data Set for Download or QSAR
maximum 50k data
Found 26 Enz. Inhib. hit(s) with all data for entry = 1594
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332027((E)-N'-(3-methoxy-2- hydroxybenzal)-2-{N-{2-[N- (n...)
Affinity DataEC50:  2.29E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM50042874(2,2'-Bipyridin | 2,2'-bipyridine | 2,2'-bipyridyl ...)
Affinity DataEC50:  4.14E+4nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332029((E)-N'-(3-ethoxy-2- hydroxybenzal)-2-{N-{2- [N-(na...)
Affinity DataEC50:  2.11E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332030((E)-N'-[(2- hydroxynaphthalen-1- yl)methylene]-2-{...)
Affinity DataEC50:  830nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332031((E)-N'-(4-N,N- diethylamino-2- hydroxybenzal)-2-{N...)
Affinity DataEC50:  780nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332032((E)-N'-(3,5-di-tert-butyl-2- hydroxybenzal)-2-{N-{...)
Affinity DataEC50:  5.23E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332033((E)-N'-(4-N,N- diethylamino-2- hydroxybenzal)-2-{N...)
Affinity DataEC50:  600nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332034((E)-N'-(2,3- dihydroxybenzal)-2-{N-{2- [N-(3- trif...)
Affinity DataEC50:  170nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332035((E)-N'-[(3-ethoxy-2- hydroxybenzal)methylene]- 2-{...)
Affinity DataEC50:  800nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332036((E)-N'-[(2- hydroxynaphthalen-1- yl)methylene]-2-{...)
Affinity DataEC50:  1.02E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332037((E)-N'-(3,5-di-tert-butyl-2- hydroxybenzal)-2-{N-{...)
Affinity DataEC50:  1.12E+4nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332038((E)-N'-(2,3- dihydroxybenzal)-2-{N-{2- [N-(4-isopr...)
Affinity DataEC50:  560nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332039((E)-N'-(3-bromo-6- hydroxybenzal)-2-{N-{2- [N-(4-i...)
Affinity DataEC50:  2.28E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332040((E)-N'-(3,5-di-tert-butyl-2- hydroxybenzal)-2-{N-{...)
Affinity DataEC50:  2.77E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332041((E)-N'-(4-N,N- diethylamino-2- hydroxybenzal)-2-{N...)
Affinity DataEC50:  760nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332042((E)-N'-(2,3- dihydroxybenzal)-2-{N-{2- [N-(3-metho...)
Affinity DataEC50:  820nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332043((E)-N'-(3-bromo-6- hydroxybenzal)-2-{N-{2- [N-(3-m...)
Affinity DataEC50:  7.19E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332044((E)-N'-[(2- hydroxynaphthalen-1- yl)methylene]-2-{...)
Affinity DataEC50:  980nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332045((E)-N'-(3,5-di-tert-butyl-2- hydroxybenzal)-2-{N-{...)
Affinity DataEC50:  7.75E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332046((E)-N'-(3-methoxy-2- hydroxybenzal)-2-{N-{2-[N- (4...)
Affinity DataEC50:  8.42E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332047((E)-N'-(3-ethoxy-2- hydroxybenzal)-2-{N-{2- [N-(4-...)
Affinity DataEC50:  2.77E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332048((E)-N'-(4-N,N-diethylamino- 2-hydroxybenzal)-2-{N-...)
Affinity DataEC50:  530nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332049((E)-N'-(3-methoxy-2- hydroxybenzal)-2-{N-{2-[N- (4...)
Affinity DataEC50:  2.76E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332050((E)-N'-(3-ethoxy-2- hydroxybenzal)-2-{N-{2-[N- (4-...)
Affinity DataEC50:  1.86E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332051((E)-N'-(4-N,N-diethylamino- 2-hydroxybenzal)-2-{N-...)
Affinity DataEC50:  130nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHypoxia-inducible factor 1-alpha(Homo sapiens (Human))
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China

US Patent
LigandPNGBDBM332028((E)-N'-(3,5-di-tert-butyl-2- hydroxybenzal)-2-{N-{...)
Affinity DataEC50:  1.78E+4nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent